Toronto Stock Exchange (TSX) · BHC.TO
Bausch Health Companies Inc.
7.9200 CAD
0(0.00%)unchanged—
Key facts
Exchange
Toronto Stock Exchange (TSX)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Market cap
2.96B CAD
Employees
20.3K
Previous close
7.92 CAD
Day range
7.86 – 8.02
52-week range
6.10 – 11.08
Volume
843.15K
About Bausch Health Companies Inc.
Bausch Health Companies Inc. is a global healthcare enterprise dedicated to the creation, production, and sale of a diverse array of pharmaceutical, medical device, and over-the-counter items. Its primary therapeutic focus areas include eye health, digestive system issues, and dermatological conditions. The company's operations are strategically organized into five key divisions: Bausch + Lomb, which specializes in vision care, surgical solutions, and ophthalmic pharmaceuticals; Salix, concentrating on gastroenterology products within the United States; International Rx, offering a broad portfolio encompassing Solta products, branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across numerous international markets in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East; Ortho Dermatologics, providing dermatological products in the U.S. and Solta medical aesthetic devices globally; and Diversified Products, covering pharmaceutical products in neurology and other therapeutic classes, alongside generic and dentistry items in the United States. Previously known as Valeant Pharmaceuticals International, Inc., the company adopted its current name in July 2018 and maintains its headquarters in Laval, Canada.
Company websiteReported annual financials
Financial statements for this issuer are on SEDAR+.
Regulatory filings
Filings for this issuer are on SEDAR+.
Insider activity
Insider filings are on SEDI.
Reader sentiment on BHC.TO
Loading…Loading votes…
Sign in to add your vote. Sentiment is reader opinion, not research.
